BASAL CELL CARCINOMA (BCC) is a slow-growing malignant skin tumor. Some believe that it arises from the hair follicle. It affects sun-exposed areas of the body, and its malignant character depends on local invasion and destruction of tissues rather than metastasis.
BCC is the most common skin cancer worldwide. In the United States, the incidence ranges from 137 to 146 per 100,000 and is even higher in other parts of the world, with the peak of 726 per 100,000 recorded in Australia. 1 Its significant morbidity and high occurrence make BCC extremely relevant to everyday practice of dermatology and create a need for an effective treatment. Several treatment modalities are currently available for BCC. These include Mohs surgery, excision surgery, electrodessication and curettage (ED&C), photodynamic therapy, topical imiquimod radiotherapy, and cryosurgery.
Cryosurgery uses low temperatures to achieve selective destruction of tissues and has been used by dermatologists from the beginning of the century to treat both benign and malignant skin conditions. Modern equipment consists of a spray-probe apparatus with liquid nitrogen that allows for deep freezing and obliteration of tissues.
Cryosurgery has many technical advantages over other methods: It is quick, safe, simple, and costeffective. In addition, it can be used in pregnancy and can be performed in an outpatient facility. It is particularly appropriate for patients who are afraid of surgery 2 and patients with pacemakers. Considering these obvious strengths of cryosurgery, it is logical to ask whether this technique is effective or as effective as other modalities. This article reviews the literature regarding the efficacy of cryosurgery treatment of BCC in terms of recurrence rates and cosmesis.
Methods
We searched MEDLINE, EMBASE, and CancerLit databases for studies published from 1966, 1980, and 1983 till 2001, respectively, using the keywords basal cell carcinoma and cryosurgery. The Cochrane Database of Systematic Reviews was searched with a keyword basal cell carcinoma. References of articles, reviews, textbooks, and guidelines were screened for further studies. We included randomized clinical trials as well as noncontrolled prospective studies reporting on recurrence rates, cosmetic results, or both. Retrospective studies, case series, investigations published in a language other than English, and studies in which BCC data were not segregated from other skin cancer data were excluded. The quality of evidence was evaluated using Sackett's grading criteria. 3 Grade A included large, randomized, double-blinded, placebocontrolled trials with low false-positive and low falsenegative errors that provide highest quality data. Grade B included randomized, double-blinded, placebo-controlled studies with high false-positive and false-negative errors because of the small number of patients. Grade C included studies that lack randomization, placebo control, or blinding, case reports, and case series.
Results
In total, 17 studies were found; of these, 15 were in MEDLINE, 1 in EMBASE, and 1 in CancerLit. No publications were found in Cochrane Library of Systematic Reviews, and screening of textbooks, references, guidelines, and reviews revealed no further studies.
It is interesting to note that the malignant nature of BCC renders placebo-controlled studies of this disease impossible. Double-blinded or even single-blinded studies are not feasible either, as both the patient and the physician must be aware of the procedure being performed. Consequently, according to Sackett's criteria, all BCC (or in general skin cancer) studies are automatically assigned grade C. Because of inability to placebo control or double blind these experiments, grade A or B studies cannot be designed.
Two types of studies were found as a result of the search: 13 noncontrolled prospective studies of patients with BCC treated with cryosurgery ( Table 1 ) and 4 clinical randomized trials ( Table 2 ). Three of these trials compared treatment of BCC with cryosurgery to other methods, and one contrasted efficacy of one versus two cycles of cryosurgery. Only one study, Wang et al., 4 reported recurrence rates as proved by the histologic clearance of tumor cells. All others based their recurrence rates on clinical diagnosis, later confirmed histologically. Most studies commented on cosmetic results of cryosurgery, but only two did so (Thissen et al. and Wang et al. 4 ) in a quantitative fashion. Randomized clinical trials are discussed later here, and prospective studies are summarized in the Table 1 .
Wang et al. 4 conducted a randomized, nonblinded clinical trial of 88 patients comparing aminolevulinic acid photodynamic therapy (ALA-PDT) and cryosurgery in the treatment of histologically verified BCC. Forty-four women and 44 men aged 42 to 88 years, comparable medically and demographically with either superficial or nodular BCC, were randomized to two treatment groups: 47 received ALA-PDT, and 41 were treated with two cycles of cryosurgery using liquid nitrogen spray technique (CRY-AC unit). In each cycle, the lesion was frozen for 25 to 30 seconds with a thawing period of 2 to 4 minutes in between cycles, depending on the thickness of the lesion. There was no information about whether the lesion was curetted before cryosurgery. The distribution of lesions was as follows: trunk 54%, head/neck 28%, legs 11%, and arm 7%. Size and thickness of the lesions were not specified. At 3 and 12 months, treatment sites were biopsied for histologic confirmation of clearance. If there was any evidence of recurrence, treatment was repeated, and a biopsy at 3 months after the last treatment was taken. The efficacy of treatment was assessed as the presence of tumor cells in punch biopsies taken at 12 months after the first treatment session. There were three protocol violations that were properly accounted for. One patient with squamous cell carcinoma (SCC) in cryosurgery group was misdiagnosed as BCC. One patient in ALA-PDT did not respond to therapy and was referred to surgery. Two patients, one in each treatment group, died for unrelated reasons. These four patients were eventually excluded from final analysis. The number of patients that had to be retreated was significantly higher in ALA-PDT group (13 of 44 or 30%) than in cryosurgery group (1 of 39 or 3%). Out of 13 ALA-PDT patients who had to be retreated, 11 required one additional treatment. One needed two and one needed three additional treatments. In the end, the frequency of BCC recurrence evaluated by punch biopsy was 25% for photodynamic therapy and 15% for cryosurgery. The difference was not statistically significant (P40.05). Tolerability and cosmetic results were assessed as well and fewer side effects such as leakage and edema (Po0.01), and better cosmetic results (Po0.001) in photodynamic therapy group were reported. The group concluded that both treatments were comparable regarding efficacy with fewer side effects and better cosmesis in PDT. However, in their statistical analysis of recurrence rate, the investigators did not account for the fact that ALA-PDT patients required a significant number of additional treatments, which is a function of the effectiveness of a given method. This major flaw of the study makes its suggestion about comparable efficacy of the two treatments inconclusive. Additionally, the 1-year follow-up period in the study was unusually short. Most investigators agree that 5 years is an appropriate amount of time to analyze adequately the recurrence rate of BCC and cancer generally. 5 Thissen et al. 6 conducted a prospective randomized study to compare cosmetic results after cryosurgery and excision for primary BCC. Male and female patients, 18 to 80 years of age with nodular or superficial types of BCC smaller than 2 cm in diameter, were recruited. Overall, 96 BCCs were treated with either surgical excision or cryosurgery. Exclusion criteria were recurrent BCCs, types other than nodular and superficial, tumors larger than 2 cm in diameter, patients with five or more BCCs, contraindications to surgery or cryosurgery, and a life expectancy less than 1 year. Forty-eight tumors were treated by excisional surgery. Direct sutures in 36 cases, transposition flaps in 11 cases, and full-thickness graft in one case were utilized for wound closure. Forty-eight tumors were treated in the cryosurgery group by a double freezethaw cycle. Each cycle consisted of 20-second freezing followed by a 60-second thaw time. Freezing was carried out by a liquid nitrogen cone-spray technique. Before freezing, lesions were thoroughly curetted with a Volkmann's curette. A large curette (no. 3) was used to debulk the lesion, and a small curette (no. 1) was used to remove the remainder of tumor cells along the borders. Although not the focus of the study, recurrence rates were evaluated 1 year after treatment: Three cryosurgery and none of the excision patients developed recurrences. Cosmetic results were evaluated by the patients and by five independent professionals who were blinded to the treatment and who were not involved in the trial at 1 year after treatment.
The group consisted of a male dermatologist, a plastic surgeon, a nurse from the dermatology department, and a beautician. Photographs were taken at the last follow-up visit and were evaluated. Evaluations were measured on a three-point scale (good, fair, and bad). The patients were asked for evaluations on a scale from 1 (very bad) to 10 (excellent) and also in terms of good, fair, or bad. As a result, the beautician had no significant preference for either therapy (cryosurgery: 21 good, 26 fair, 1 bad; excision: 28 good, 19 fair, 1 bad, with odds ratio 5 1.8; Po0.15; 95% confidence interval, 0.8 to 4). According to patients, excision led to better results, but the difference was very small (cryosurgery: 42 good, 6 fair, 0 bad; excision: 48 good, 0 fair, 0 bad, OR, P value, and 95% confidence interval are not given). On a 10-point scale, cryosurgery received 7.58 and excision 8.87 points. All clinical professionals evaluated excision surgery as much better than cryosurgery. For example, the plastic surgeon assigned the following values for cryosurgery: 15 good, 14 fair, 24 bad; and for excision, the values were 37 good, 9 fair, 2 bad, with OR 5 12.5, Po0.01, and 95% confidence interval, 0.7 to 33.3. Based on these data, the investigators concluded that cosmetic results after excision are better than after cryosurgery. However, their conclusion is based on the opinion of clinical professionals, who could have been biased, and not patients, or a beautician. The group was blinded to the treatment, but a trained eye can tell the difference between a cryosurgical and excisional surgical scar. In a randomized trial, Mallon and Dawbor 7 compared the efficacy of one freeze-thaw cycle versus two freeze-thaw cycles in the treatment of facial BCCs. In addition, they investigated the efficacy of one freeze-thaw cycle in the treatment of superficial truncal BCCs in a prospective posttreatment followup study. Eighty-four facial BCCs were treated. Most tumors were diagnosed clinically. Only lesions of 1.5 cm or less were included. Morpheaform BCCs were excluded. Patients were randomly allocated to either a single 30-second or double 30-second freeze-thaw cycle. The thaw time between 30-second freezes was at least 60 seconds. The lesions were not curetted. They were delineated with a skin marker pen before cryosurgery. Forty-eight lesions received two cycles, and 36 lesions received one cycle. The follow-up period ranged from 1.2 to 6.1 years in two-cycle group and 10 months to 7.1 years in one-cycle group. Also, 29 superficial BCCs of less than 2 cm in diameter on the trunk were treated with one 30-second cycle and were followed for 2.1 to 4.1 years. Seven patients with facial BCC defaulted from follow-up. The recurrence rate was significantly higher in a group treated with one freeze-thaw cycle (20.6%) than in a group treated with two cycles (4.7%). The recurrence rate in a group with BCCs of the trunk who received one freeze-thaw cycle was 4.5%. Consequently, the investigators recommended the use of two cycles of cryosurgery on the face and one cycle on the trunk. The promising treatment results of the trunk should be taken with caution because of a small sample size of only 29 lesions. In addition, some patients in that group were followed for as little as 10 months, which is not a sufficient amount of time to detect recurrence.
Hall et al. 8 carried on a prospective randomized trial of 93 patients to compare radiotherapy with cryosurgery in treatment of BCC. Recurrent tumors were excluded. Tumors on the nose or pinna were excluded as well. All lesions were smaller than 2 cm in diameter. The histologic type of the lesions was not specified. Forty-nine randomly chosen patients were treated with radiotherapy and 44 with cryosurgery. Radiotherapy was applied with 130-kV x-rays, generated at 5 mA and with filter of 1 mm A1. Tumors smaller than 1 cm in diameter were treated with 5 fractions of 700 cGy in 5 days. Lesions larger than 1 cm in diameter were treated with 375 cGy in 10 treatments over 12 days. Cryosurgery was carried out as two freeze-thaw cycles, freezing for 1 minute each time, with a thaw time for at least 90 seconds. The authors did not mention curetting the lesions. Patients were reviewed for presence or absence of recurrences at 1, 6, 12, and 24 months after treatment. After a year, 17 patients had histologically proven recurrent disease (39%) in the cryosurgery group, and two patients (4%) had recurrence in the radiotherapy group. The investigators concluded that cryosurgery is an unacceptable method of treatment. The results of this early trial (1983) are contradicted by later studies (Tables 1 and 2) with overwhelming amount of evidence that cryosurgery treatment of BCC results in recurrence rates of (less than 10%). The study did not specify the type of BCC treated. Possibly, morpheaform or recurrent BCCs were included in the study, and in this way, the recurrence rate was higher. In addition, at the time of the study, cryosurgery techniques were only evolving, and the inexperience with the technique could have skewed the results.
Conclusion
As shown by best evidence (Table 1) , cryosurgery is an effective treatment for BCC, with cure rates established clinically to be above 90% and have been used for nodular and superficial types of BCC on the trunk, limbs, head and neck, including eyelids, and ears. The size of the lesion in most studies was smaller than 2 cm; however, there are reports of successful treatment of larger lesions. [9] [10] [11] Most investigators specifically excluded treatment of the recurrent or morpheaform type of BCC in their experiments. There are only two prospective studies of the recurrent or morpeaform BCC 12, 13 with promising data, and thus, at this point, there is not enough evidence supporting the use of cryosurgery for these ''difficult'' to treat types of BCC. In fact, most investigators agree that a tumor with illdefined borders such as morpheaform BCC is a contraindication for cryosurgery because this technique, unlike surgery, does not provide a biopsy specimen that can be analyzed for tumor-free margins.
Most commentators recommend using two freezethaw cycles. 2 Successful treatment of trunk BCCs with only one cycle of cryosurgery as shown by Mallon et al. is interesting but not convincing because of the small sample size and a short follow-up period. In fact, the same study showed that the use of one freeze-thaw cycle on the face led to an unacceptably high recurrence (20.6%). Many investigators report curetting lesions before freezing in order to define the tumor borders as well as remove some of the cancerous cells. There are no studies, however, with data on how curetting affects the efficiency of cryosurgery treatment. In fact, slightly different recurrence rates reported by investigators were affected by differences in the treatment protocol.
Contraindications to cryosurgery include cold sensitivity, cryoglobulinemia, cryofibrinogenemia, Raynoud's disease, autoimmune disease, platelet disorders, and tumor with ill-defined borders. 14 The most common side effects are minor and temporary and include edema, pain, and erythema. 15 Rare complications include delayed bleeding, infection, syncope, pyogenic granuloma, and hypertrophic scarring. 16, 17 Cosmetic results have been qualitatively described as good in literature. 4, [7] [8] [9] [10] [11] [12] [13] The Thissen et al. study focused on cosmetic aspect of cryosurgery in treatment of BCC as compared with excision surgery. The study suggests that better cosmetic results are achieved with excision. This conclusion is based on the evaluation by clinical professionals (dermatologist, plastic surgeon, and dermatologic nurse). Interestingly, according to the beautician, there was no significant difference between the two treatments. Patients showed slight preference for excision, but the difference was very small. Patient's satisfaction is a valuable measure of treatment success (no patients regarded cryosurgery or excisional surgery as ''bad''). The evaluation of an unbiased beautician may be more relevant to the general public than the opinion of professionals such as a plastic surgeon.
Cryosurgery is an effective method to treat BCC, but unfortunately, there is no direct good evidence of whether it is in fact more or less effective than other modalities. Despite the fact that there are many publications reporting on recurrence rates for other treatment options such as Mohs surgery, 18 excisional surgery, 19 or radiotherapy, 20 these studies are not uniform, and the results cannot be directly compared. 21 Consequently, there is a need for randomized clinical trials providing data on the efficacy of cryosurgery as contrasted with other techniques. Future investigators should consider the use of histologic clearance as an outcome measure. In spite of some weaknesses, the study of Wang et al. is novel in that it assessed efficacy in terms of histologic, as opposed to clinical, recurrence.
